News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ASLAN Signs Up JHL To Provide Process Development For Asthma Treatment



11/16/2016 9:32:27 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
ASLAN Pharma of Singapore engaged JHL Biotech, a Taiwan/China CMO, to provide biologic process development services and clinical trial supplies of ASLAN004. ASLAN004 is a fully human monoclonal antibody that blocks the signaling of the IL-4 and IL-13 receptors. Work will start in 2016 in JHL's GMP-certified facility in Zhubei, Taiwan. ASLAN secured worldwide rights to ASLAN004 from CSL Behring in 2014, originally for asthma, though it is also developing the molecule to treat cancer.

Read at BioSpace.com


comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES